Abstract10.1016/j.annonc.2024.05.472329P Nadunolimab, a first-in-class monoclonal antibody against IL1RAP, in advanced pancreatic cancerJun 01, 2024Annals of OncologyE Van Cutsem + 7 more +7RelevantCiteListenSave